Cleveland Clinic has joined 23andMe to recruit Parkinson’s patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Read MoreInitial studies funded by the Michael J. Fox Foundation show Harbor BioSciences’ Triolex for Parkinson’s disease crosses the blood-brain barrier in mice.
Read More
Positive Early Results for Parkinson’s Treatment Michael J. Fox Harbor BioSciences, San Diego, which is investigating the use the company’s proprietary compound Triolex as a treatment for Parkinson’s disease (PD) with fund
Read MoreResearch provides new insight into the compulsive behavior and cognitive defects associated with the neurological disorder called Lesch-Nyhan Disease.
Read MoreResearch provides new insight into the compulsive behavior and cognitive defects associated with the neurological disorder called Lesch-Nyhan Disease.
Read More